Last Posted: Jun 24, 2019
- Germline pathogenic variants in 7,636 Japanese patients with prostate cancer and 12,366 controls.
Momozawa Yukihide et al. Journal of the National Cancer Institute 2019 Jun - Whole Exome Sequencing Identifies Putative Predictors of Recurrent Prostate Cancer with High Accuracy.
Liu Jie et al. Omics : a journal of integrative biology 2019 Jun - Large Chromosomal Rearrangements Yield Biomarkers to Distinguish Low-Risk From Intermediate- and High-Risk Prostate Cancer.
Vasmatzis George et al. Mayo Clinic proceedings 2019 94(1) 27-36 - Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
Paller Channing J et al. Clinical genitourinary cancer 2019 Apr - Prostate cancer genomics: comparing results from three molecular assays.
Alam Syed et al. The Canadian journal of urology 2019 Jun 26(3) 9758-9762 - Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer
K Nagpal et al, NPJ Digital Medicine, June 7, 2019 - Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsy.
Lin Chia-Yen et al. Urologic oncology 2019 May - Clinical implications of genetic aberrations in metastatic prostate cancer.
Reichert Zachery R et al. Current opinion in urology 2019 Jul 29(4) 319-325 - NCCN Guidelines Updates: Management of Prostate Cancer.
Mohler James L et al. Journal of the National Comprehensive Cancer Network : JNCCN 2019 May 17(5.5) 583-586 - User-testing an interactive option grid decision aid for prostate cancer screening: lessons to improve usability.
Scalia Peter et al. BMJ open 2019 May 9(5) e026748
.png)
No hay comentarios:
Publicar un comentario